Scorpion venom component III inhibits cell proliferation by modulating NF-κB activation in human leukemia cells

Experimental and Therapeutic Medicine

Volumn 4, Issue 1, 2012, Pages 146-150

  Song, Xiangfeng ^a,b   Zhang, Guojun ^b   Sun, Aiping ^b   Guo, Jiqiang ^b   Tian, Zhongwei ^b   Wang, Hui ^b   Liu, Yufeng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Cell cycle; Leukemia; Nuclear factor B; Scorpion venom

Indexed keywords

CYCLIN D1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; SCORPION VENOM; SCORPION VENOM COMPONENT 3; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE;

EID: 84865748382     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.548     Document Type: Article

References (31)

1. Batista C V F, Pozo L D, Zamudio F Z, Contreras S, Becerril B, Wanke E and Possani LD: Proteomics of the venom from the Amazonian scorpion Tityus cambridgei and the role of prolines on mass spectrometry analysis of toxins. J Chromatogr B Analyt Technol Biomed Life Sci 803: 55-66, 2004.
2. Zargan J, Sajad M, Umar S, Naime M, Ali S and Khan HA: Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest. Exp Mol Pathol 91: 447-454, 2011.
3. Gao F, Li H, Chen YD, Yu XN, Wang R and Chen XL: Upregulation of PTEN involved in scorpion venom-induced apoptosis in a lymphoma cell line. Leuk Lymphoma 50: 633-641, 2009.
4. Zargan J, Sajad M, Umar S, Naime M, Ali S and Khan HA: Scorpion (Odontobuthus doriae) venom induces apoptosis and inhibits DNA synthesis in human neuroblastoma cells. Mol Cell Biochem 348: 173-181, 2011.
5. Hayden MS, West AP and Ghosh S: NF-κB and the immune response. Oncogene 25: 6758-6780, 2006.
6. Garg A and Aggarwal BB: Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 16: 1053-1068, 2002.
7. Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A and Zamora A: The transcription factor nuclear factor-κB and cancer. Clin Oncol (R Coll Radiol) 19: 154-161, 2007.
8. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
9. Gupta SD, Gomes A, Debnath A, Saha A and Gomes A: Apoptosis induction in human leukemic cells by a novel protein Bengalin, isolated from Indian black scorpion venom: through mitochondrial pathway and inhibition of heat shock proteins. Chem Biol Interact 183: 293-303, 2010.
10. Das Gupta S, Debnath A, Saha A, Giri B, Tripathi G, Vedasiromoni JR and Gomes A: Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. Leukemia Res 31: 817-825, 2007.
11. Fan S, Sun Z, Jiang D, Dai C, Ma Y, Zhao Z, Liu H, Wu Y, Cao Z and Li W: BmKCT toxin inhibits glioma proliferation and tumor metastasis. Cancer Lett 291: 158-166, 2010.
12. Fu YJ, Yin LT, Liang AH, Zhang CF, Wang W, Chai BF, Yang JY and Fan XJ: Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neurosci Lett 412: 62-67, 2007.
13. Wang WX and Ji YH: Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro. J Neurooncol 73: 1-7, 2005.
14. D'Suze G, Rosales A, Salazar V and Sevcik C: Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line. Toxicon 56: 1497-1505, 2010.
15. Zhang YY, Wu LC, Wang ZP, Wang ZX, Jia Q, Jiang GS and Zhang WD: Anti-proliferation effect of polypeptide extracted from scorpion venom on human prostate cancer cells in vitro. J Clin Med Res 1: 24-31, 2009.
16. Omran MAA: In vitro anticancer effect of scorpion Leiurus quinquestriatus and Egyptian Cobra venom on human breast and prostate cancer cell lines. J Med Sci 3: 66-86, 2003.
17. Bonizzi G and Karin M: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288, 2004.
18. Yamamoto M and Takeda K: Role of nuclear IkappaB proteins in the regulation of host immune responses. J Infect Chemother 14: 265-269, 2008.
19. Wu Y and Zhou BP: TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 102: 639-644, 2010.
20. Sarkar FH, Li Y, Wang Z and Kong D: NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol 27: 293-319, 2008.
21. Nishikori M: Classical and alternative NF-κB activation pathways and their roles in lymphoid malignancies. J Clin Exp Hematopathol 45: 15-24, 2005.
22. Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH, Cheng SH, Tsang CM, Tsao SW and Chan AT: A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. Cancer Lett 287: 23-32, 2010.
23. Warfel JM and D'Agnillo F: Anthrax lethal toxin enhances TNF-induced endothelial VCAM-1 expression via an IFN regulatory factor-1-dependent mechanism. J Immunol 180: 7516-7524, 2008.
24. Qiao Q, Nozaki Y, Sakoe K, Komatsu N and Kirito K: NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma. Exp Hematol 38: 1199-1208, 2010.
25. Huber AV, Saleh L, Prast J, Haslinger P and Knöfler M: Human chorionic gonadotrophin attenuates NF-kappaB activation and cytokine expression of endometriotic stromal cells. Mol Hum Reprod 13: 595-604, 2007.
26. Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu Rev Immunol 18: 621-663, 2000.
27. Korn SH, Wouters EF, Vos N and Janssen-Heininger YM: Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem 276: 35693-35700, 2001.
28. Kumar A, Takada Y, Boriek AM and Aggarwal BB: Nuclear factor-κB: its role in health and disease. J Mol Med 82: 434-448, 2004.
29. Sethi G, Sung B and Aggarwal BB: Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 233: 21-31, 2008.
30. Biliran H Jr, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, cfBollig A, Sarkar FH and Liao JD: Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatinmediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin Cancer Res 11: 6075-6086, 2005.
31. Sung B, Ahn KS and Aggarwal BB: Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway. Cancer Res 70: 3259-3268, 2010.